Patient out-of-pocket costs for cannabis use during cancer treatment.

Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, Jun J Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Deborah Korenstein, Helena Furberg-Barnes, Talya Salz, Fumiko Chino
{"title":"Patient out-of-pocket costs for cannabis use during cancer treatment.","authors":"Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, Jun J Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Deborah Korenstein, Helena Furberg-Barnes, Talya Salz, Fumiko Chino","doi":"10.1093/jncimonographs/lgad030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We assessed patient costs associated with cannabis use during cancer treatment.</p><p><strong>Methods: </strong>Adults treated for cancer at a large, comprehensive center completed an anonymous survey regarding their thoughts and experiences with cannabis and cancer. Bivariate and weighted multivariable logistic regression assessed clinical and sociodemographic factors associated with patient-reported out-of-pocket costs for cannabis products.</p><p><strong>Results: </strong>Overall, 248 cannabis users provided data on cost and were analyzed. Median monthly out-of-pocket cost for cannabis was $80 (interquartile range = $25-$150). On regression analysis, male gender (odds ratio = 2.5, 95% confidence interval = 1.2 to 5.5, P = .026) and being 45 years of age or older (odds ratio = 7.5, 95% confidence interval = 1.9 to 30.0, P = .0042) were associated with spending $100 a month or more on cannabis. Of the 166 patients who stopped using cannabis early or used less than preferred, 28% attributed it to cost and 26% to lack of insurance coverage.</p><p><strong>Conclusion: </strong>Cannabis use during cancer treatment may contribute to significant out-of-pocket costs, with men and younger patients more likely to pay higher costs.</p>","PeriodicalId":73988,"journal":{"name":"Journal of the National Cancer Institute. Monographs","volume":"2024 66","pages":"305-312"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303855/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute. Monographs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncimonographs/lgad030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We assessed patient costs associated with cannabis use during cancer treatment.

Methods: Adults treated for cancer at a large, comprehensive center completed an anonymous survey regarding their thoughts and experiences with cannabis and cancer. Bivariate and weighted multivariable logistic regression assessed clinical and sociodemographic factors associated with patient-reported out-of-pocket costs for cannabis products.

Results: Overall, 248 cannabis users provided data on cost and were analyzed. Median monthly out-of-pocket cost for cannabis was $80 (interquartile range = $25-$150). On regression analysis, male gender (odds ratio = 2.5, 95% confidence interval = 1.2 to 5.5, P = .026) and being 45 years of age or older (odds ratio = 7.5, 95% confidence interval = 1.9 to 30.0, P = .0042) were associated with spending $100 a month or more on cannabis. Of the 166 patients who stopped using cannabis early or used less than preferred, 28% attributed it to cost and 26% to lack of insurance coverage.

Conclusion: Cannabis use during cancer treatment may contribute to significant out-of-pocket costs, with men and younger patients more likely to pay higher costs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症治疗期间使用大麻的患者自付费用。
背景:我们评估了患者在癌症治疗期间使用大麻的相关费用:在一家大型综合中心接受癌症治疗的成年人完成了一项匿名调查,内容涉及他们对大麻和癌症的看法和经历。双变量和加权多变量逻辑回归评估了与患者报告的大麻产品自付费用相关的临床和社会人口因素:共有 248 名大麻使用者提供了费用数据并进行了分析。每月大麻自付费用的中位数为 80 美元(四分位间范围 = 25-150 美元)。在回归分析中,男性(几率比 = 2.5,95% 置信区间 = 1.2 至 5.5,P = .026)和 45 岁或以上(几率比 = 7.5,95% 置信区间 = 1.9 至 30.0,P = .0042)与每月 100 美元或以上的大麻费用相关。在 166 名提前停止使用大麻或使用量少于首选量的患者中,28% 的人归因于费用,26% 的人归因于缺乏保险:结论:在癌症治疗期间使用大麻可能会导致大量的自付费用,男性和年轻患者更有可能支付更高的费用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
0
期刊最新文献
Challenges to and considerations of designing cancer prevention trials. Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally. Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1